Malignant Anal Neoplasm — Trials

Malignant Anal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 68
Recruiting: 34
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%
Trials / 1,000 deaths: 42.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04157985	Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors	completed	Phase 3	161	Dan ZandbergOTHER	1	Dec 11, 2025	clinicaltrials
NCT04534075	Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial(FIDURA)	completed	Phase 3	354	Sahlgrenska University HospitalOTHER	1	Sep 8, 2025	clinicaltrials